Modifying clopidogrel maintenance doses according to vasodilator-stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance. [electronic resource]
Producer: 20110916Description: 332-8 p. digitalISSN:- 1932-8737
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Cardiovascular Diseases -- prevention & control
- Cell Adhesion Molecules
- Clopidogrel
- Coronary Angiography
- Drug Resistance
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Microfilament Proteins
- Phosphoproteins
- Platelet Aggregation Inhibitors -- administration & dosage
- Statistics as Topic
- Ticlopidine -- administration & dosage
- Treatment Outcome
- Vasodilation -- drug effects
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.